| # | Title | Journal | Year | Citations |
|---|
| 1 | Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia | Journal of the American Medical Directors Association | 2014 | 3,035 |
| 2 | Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial | Lancet, The | 2019 | 2,347 |
| 3 | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Gastroenterology | 2015 | 2,200 |
| 4 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial | Lancet Oncology, The | 2012 | 1,879 |
| 5 | Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis | The Lancet Global Health | 2019 | 1,839 |
| 6 | Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study | Lancet, The | 2016 | 1,414 |
| 7 | Chronic Inflammation and Cytokines in the Tumor Microenvironment | Journal of Immunology Research | 2014 | 1,246 |
| 8 | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial | Lancet, The | 2007 | 1,185 |
| 9 | Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus | Nature Immunology | 2016 | 781 |
| 10 | Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans | Science | 2010 | 780 |
| 11 | Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial | Lancet, The | 1999 | 734 |
| 12 | Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever | Nature Medicine | 2003 | 707 |
| 13 | Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial | Lancet Oncology, The | 2014 | 695 |
| 14 | Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report | Pediatrics | 2010 | 690 |
| 15 | 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial | Lancet Oncology, The | 2016 | 623 |
| 16 | The global epidemiology of preterm birth | Best Practice and Research in Clinical Obstetrics and Gynaecology | 2018 | 538 |
| 17 | Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis | PLoS Medicine | 2014 | 507 |
| 18 | Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection | Journal of Gastroenterology and Hepatology (Australia) | 2009 | 493 |
| 19 | Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 479 |
| 20 | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy | Clinical Cancer Research | 2015 | 427 |
| 21 | Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Gastroenterology | 2013 | 423 |
| 22 | A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus | Nature Immunology | 2015 | 415 |
| 23 | Are Ducks Contributing to the Endemicity of Highly Pathogenic H5N1 Influenza Virus in Asia? | Journal of Virology | 2005 | 407 |
| 24 | Vascular Leakage in Severe Dengue Virus Infections: A Potential Role for the Nonstructural Viral Protein NS1 and Complement | Journal of Infectious Diseases | 2006 | 397 |
| 25 | Sublingual immunotherapy: World Allergy Organization position paper 2013 update | World Allergy Organization Journal | 2014 | 395 |
| 26 | Melioidosis: Review and Update | Clinical Infectious Diseases | 1989 | 385 |
| 27 | Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives | Intensive Care Medicine | 2016 | 352 |
| 28 | Health impacts of parental migration on left-behind children and adolescents: a systematic review and meta-analysis | Lancet, The | 2018 | 331 |
| 29 | International consensus on (ICON) pediatric asthma | Allergy: European Journal of Allergy and Clinical Immunology | 2012 | 327 |
| 30 | Human Disease from Influenza A (H5N1), Thailand, 2004 | Emerging Infectious Diseases | 2005 | 319 |
| 31 | Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome | Journal of the American College of Cardiology | 2015 | 315 |
| 32 | Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study | Journal of Antimicrobial Chemotherapy | 2011 | 314 |
| 33 | Role of the Acetabular Labrum and the Iliofemoral Ligament in Hip Stability | American Journal of Sports Medicine | 2011 | 307 |
| 34 | Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study | Antimicrobial Agents and Chemotherapy | 2012 | 291 |
| 35 | Risk Factors for Melioidosis and Bacteremic Melioidosis | Clinical Infectious Diseases | 1999 | 285 |
| 36 | Dengue Virus Infection of Human Endothelial Cells Leads to Chemokine Production, Complement Activation, and Apoptosis | Journal of Immunology | 1998 | 285 |
| 37 | Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial | Lancet Oncology, The | 2013 | 280 |
| 38 | Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial | Hepatology | 2014 | 279 |
| 39 | Efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial | Lancet Neurology, The | 2016 | 279 |
| 40 | The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves | Journal of Ethnopharmacology | 2008 | 275 |
| 41 | The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis | MSphere | 2017 | 274 |
| 42 | Liver fluke-associated cholangiocarcinoma | British Journal of Surgery | 2002 | 267 |
| 43 | A variant in the CD209 promoter is associated with severity of dengue disease | Nature Genetics | 2005 | 267 |
| 44 | High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia | American Journal of Respiratory and Critical Care Medicine | 2011 | 267 |
| 45 | Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma | Cancer | 1998 | 264 |
| 46 | Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line | Journal of Ethnopharmacology | 2004 | 257 |
| 47 | A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter | Science | 2006 | 254 |
| 48 | Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial | Journal of Nutritional Biochemistry | 2014 | 245 |
| 49 | T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal? | Journal of Immunology | 2006 | 244 |
| 50 | Nurses as substitutes for doctors in primary care | The Cochrane Library | 2019 | 243 |
